Monitor for actual sales via subsequent Form 4 filings. The cluster of intent-to-sell filings from a director and two Atlas Venture funds suggests potential near-term overhang. Given the small relative size, the direct price impact is likely limited, but the signal may weigh on sentiment. Watch for any upcoming catalyst (e.g., data readouts) that could accelerate or delay execution of these sales.
Price Chart
Executive Summary
Three Form 144 filings from Kymera Therapeutics on June 17, 2026, signal intent to sell by director Bruce Booth (11,741 shares, ~$1.03M) and two Atlas Venture entities (Atlas Venture Fund X: 92,169 shares, ~$8.06M; Atlas Venture Opportunity Fund I: 12,902 shares, ~$1.13M). Combined proposed sales total ~116,812 shares worth ~$10.2M, representing ~0.14% of shares outstanding. While the dollar amount is modest relative to the $7.2B market cap, the coordinated filing by a director and major venture backers on the same day is a mildly negative signal.
Key Facts
- Bruce Booth (Director) filed to sell 11,741 shares valued at ~$1,026,633.
- Atlas Venture Fund X, L.P. filed to sell 92,169 shares valued at ~$8,059,257.
- Atlas Venture Opportunity Fund I, L.P. filed to sell 12,902 shares valued at ~$1,128,151.
- Total proposed sales: 116,812 shares worth ~$10,214,041.
- All three filings were made on June 17, 2026, indicating coordinated insider/affiliate selling intent.
- Shares to be sold were acquired via stock options (Booth) and private placements (Atlas) in 2020.
Financial Impact
Proposed sales of ~$10.2M, representing ~0.14% of market cap ($7.2B).
Risk Factors
- Insider selling may signal lack of confidence in near-term prospects.
- Potential overhang if all shares are sold within the 90-day window.
- Further selling by other insiders or affiliates could follow.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (KYMR) — Batch item 1 | 0001628280-26-044009 |
| Document: 0001628280-26-044009-index.html | 0001628280-26-044011 |
| Document: 0001628280-26-044009.txt | 0001628280-26-044012 |
| 144 Filing (KYMR) — Batch item 4 | 0001628280-26-044011 |
| Document: 0001628280-26-044011-index.html | 0001628280-26-044009 |
| Document: 0001628280-26-044011.txt | 0001628280-26-044009 |
| 144 Filing (KYMR) — Batch item 7 | 0001628280-26-044012 |
| Document: 0001628280-26-044012-index.html | 0001628280-26-044009 |
| Document: 0001628280-26-044012.txt | 0001628280-26-044009 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 8-K | $105.48 $118.63 | ▲ +12.47% | ▲ +13.07% | $107.39 (+1.81%) |
Jul 8, 2026 12w ago | Insider Cluster | $114.16 $105.48 | ▲ +7.60% | ▲ +10.88% | $107.39 (+5.93%) |
Jul 2, 2026 13w ago | Insider Cluster | $113.51 $107.01 | ▲ +5.73% | ▲ +5.31% | $107.39 (+5.39%) |
Jul 2, 2026 13w ago | Insider Cluster | $113.51 $107.01 | ▲ +5.73% | ▲ +5.31% | $107.39 (+5.39%) |
Jun 30, 2026 13w ago | 144 | $114.20 $105.25 | ▲ +7.84% | ▲ +5.65% | $107.39 (+5.96%) |
Jun 29, 2026 13w ago | 144 | $114.67 $110.05 | ▼ −4.03% | ▼ −3.00% | $107.39 (−6.35%) |
Jun 26, 2026 13w ago | Insider Cluster | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 26, 2026 13w ago | 144 | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 26, 2026 14w ago | 144 | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 24, 2026 14w ago | 144 | $116.46 $110.38 | ▼ −5.22% | ▼ −5.75% | $107.39 (−7.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access